Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01180 |
| Species: | Homo sapiens |
| Position : | chr22:27493955-27497536 |
| Year: | 2024 |
| Title: | A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | pancreatic ductal adenocarcinoma |
| PMID: | 39333082 |
| MONDO: | MONDO:0005184 |
| Tissue: | pancreas |
| Tissue Ontology ID: | UBERON:0001264 |
| Cell Source: | BxPC-3 |
| CVCL ID: | CVCL_0186 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay, Chromatin interaction assay; Disease-variant functional analysis; In vivo functional validation |
| High Throughput Method: | scATAC-seq, scRNA-seq, scCUT&Tag |
| Low Throughput Method: | Transgenic Reporter Assay; In vivo phenotyping |
| Target gene : | MN1 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|